TRIPLEPOINT VEN.GR.DL-,01 WKN: A1XFEK ISIN: US89677Y1001 Forum: Aktien Thema: Hauptdiskussion

TriplePoint Venture Growth NII of $0.58 beats by $0.11, revenue of $34.95M beats by $2.02M https://seekingalpha.com/pr/19152795-triplepoint-venture-growth-bdc-corp-announces-fourth-quarter-and-fiscal-year-2022-financial INCREASES DISTRIBUTION BY 8% TO $0.40 PER SHARE FOR THE FIRST QUARTER 2023 NET ASSET VALUE As of December 31, 2022, the Company’s net assets were $419.9 million, or $11.88 per share, as compared to $434.5 million, or $14.01 per share, as of December 31, 2021.

Denen ist wohl ein Unternehmen hopps gegangen. Zu finden unter den Kommentaren zur Special Dividend TriplePoint Venture Growth declares $0.10 special dividend https://seekingalpha.com/news/3916101-triplepoint-venture-growth-declares-010-special-dividend ... More importantly, there was an 8-K SEC filing discussing its investments in Medly Health, which has been placed on non-accrual related to the "recent negative developments" Medly (also discussed last month). Medly has filed for bankruptcy protection, resulting in a downgrade to rating 5 (red) under its credit watch list and a full write-down of the fair value of its investment. TPVG had a total exposure of around $32.5 million to Medly, which is around $0.92 per share or 7.3% of its NAV per share...

Schau dir doch Capital Southwest, Trinity Capital, Hercules Capital, Ares Capital und Main( Main Street Capital) an. Vielleicht ist was für dich dabei!!!OWL evtl. und sixth street specialty lending noch interessant :)

https://seekingalpha.com/article/4555868-bdcs-trinity-attractive-than-triplepoint-venture-growth

Heute entdeckt und werde einsteigen. Sehen immer noch professionell und profitabel aus

Guten Morgen, nein ich bin hier nicht investiert! Hat sich irgendwie nicht ergeben.

https://www.marketbeat.com/instant-alerts/nyse-tpvg-consensus-analyst-rating-2021-01/

Servus, Chime und And0 seit ihr mittlerweile investiert?

Hier noch einer dabei?

Noch dabei? Gleich kommt glaube ich ein guter EK.

TriplePoint Venture Growth (NYSE:TPVG): Q3 GAAP EPS of $0.46 beats by $0.02. Total investment income of $17.7M (+69.9% Y/Y) beats by $1.65M.

Knapp 12 % Dividende und zu 100 % gedeckt aus den Einnahmen. Gutes Payout Ratio

Heute eingestiegen vor den Q-Zahlen und dem Abverkauf dank der Marktlage. Q-Zahlen werden sehr gut ausfallen

Erster